World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
150
Citations
108264
World Ranking
1144
National Ranking
660

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Philip W. Kantoff is affiliated with Memorial Sloan Kettering Cancer Center in the United States and has a robust research portfolio predominantly in medicine, with significant contributions to biochemistry, genetics, and molecular biology.

Their research spans several subfields, including pulmonary and respiratory medicine, molecular biology, cancer research, oncology, and genetics. The work covers diverse topics such as prostate cancer treatment and research, prostate cancer diagnosis and treatment, cancer lipids and metabolism, statistical methods in clinical trials, cancer genomics and diagnostics, cancer immunotherapy and biomarkers, and PARP inhibition in cancer therapy.

Philip W. Kantoff has published extensively, with notable works including:

  • TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?, 2020, Cancer Discovery
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019, 2020, European Urology
  • Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer, 2020, Clinical Cancer Research
  • Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors, 2021, JAMA Oncology
  • Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations, 2020, JCO Precision Oncology

Their frequent co-authors include Lorelei A. Mucci, Konrad H. Stopsack, Travis Gerke, Michael J. Morris, and Subhiksha Nandakumar.

The venues in which Philip W. Kantoff frequently publishes are:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • Cancer
  • UNC Libraries

Philip W. Kantoff has been recognized as a member of the Association of American Physicians. Their contributions are part of ongoing clinical and molecular investigations related to prostate cancer and other oncology-related fields.

Best Publications

  • Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

    Philip W. Kantoff;Celestia S. Higano;Neal D. Shore;E. Roy Berger

  • Cancer nanomedicine: progress, challenges and opportunities.

    Jinjun Shi;Philip W. Kantoff;Richard Wooster;Omid C. Farokhzad;Omid C. Farokhzad

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Gene expression correlates of clinical prostate cancer behavior.

    Dinesh Singh;Phillip G. Febbo;Phillip G. Febbo;Kenneth Ross;Donald G. Jackson

  • Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

    Omid C. Farokhzad;Jianjun Cheng;Jianjun Cheng;Benjamin A. Teply;Ines Sherifi

  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

    Howard I. Scher;Susan Halabi;Ian Tannock;Michael Morris

  • Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

    Christopher E. Barbieri;Sylvan C. Baca;Sylvan C. Baca;Michael S. Lawrence;Francesca Demichelis;Francesca Demichelis

  • Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    Colin C. Pritchard;Joaquin Mateo;Michael F. Walsh;Navonil De Sarkar

  • The genomic complexity of primary human prostate cancer

    Michael F. Berger;Michael F. Berger;Michael S. Lawrence;Francesca Demichelis;Yotam Drier

  • Punctuated Evolution of Prostate Cancer Genomes

    Sylvan C Baca;Davide Prandi;Michael S Lawrence;Juan Miguel Mosquera

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Early detection of prostate cancer: AUA Guideline

    H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

    Jeffrey Hrkach;Daniel Von Hoff;Mir Mukkaram Ali;Elizaveta Andrianova

  • Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

    Toni K. Choueiri;Bernard Escudier;Thomas Powles;Paul N. Mainwaring

  • Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer

    Vaishali Bagalkot;Liangfang Zhang;Etgar Levy-Nissenbaum;Sangyong Jon

  • Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

    Philip W. Kantoff;Thomas J. Schuetz;Brent A. Blumenstein;L. Michael Glode

  • Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

    Philip W. Kantoff;Susan Halabi;Mark Conaway;Joel Picus

  • Genomic correlates of clinical outcome in advanced prostate cancer.

    Wassim Abida;Joanna Cyrta;Joanna Cyrta;Glenn Heller;Davide Prandi

  • The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

    Edward Giovannucci;Meir J. Stampfer;Krishna Krithivas;Myles Brown

Frequent Co-Authors

Lorelei A. Mucci
Lorelei A. Mucci Harvard University
William Oh
William Oh Icahn School of Medicine at Mount Sinai
Anthony V. D'Amico
Anthony V. D'Amico Brigham and Women's Hospital
Mary-Ellen Taplin
Mary-Ellen Taplin Harvard University
Massimo Loda
Massimo Loda Cornell University
Meir J. Stampfer
Meir J. Stampfer Harvard University
Christopher Sweeney
Christopher Sweeney Harvard University
Mark A. Rubin
Mark A. Rubin University of Bern
Ming-Hui Chen
Ming-Hui Chen University of Connecticut
Eric J. Small
Eric J. Small University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in health professions but aren’t set on becoming a physician, there are several flexible and rewarding options. For those looking to begin a healthcare career quickly, medical coding and billing classes online with financial aid offer a fast route into the administrative side of medicine.

Nursing is another highly sought-after field. Some schools now make it easier to start your journey, such as by offering a nursing school without teas test, removing a common admission barrier.

If you are interested in the leadership and operations side of healthcare, consider a health care administration degree online to open doors to hospital and clinic management roles.

Registered nurses aiming to advance their careers can look at bridge programs like adn to fnp, which fast-track your way to becoming a Family Nurse Practitioner.

These diverse, online pathways allow you to make a rapid impact in healthcare, with options suited to both clinical and non-clinical interests.

Best Scientists Citing Philip W. Kantoff

Trending Scientists

Recently Published Articles